1-4 of 4
vascular patency
Close
Sort by
Journal Articles

GBT1118 Diminishes Vaso-Occlusion in Sickle Cell Disease Mice

Carsten Alt, PhD, Perry Liu, Chien-Ming Li, PhD, Abel Silva, Peter Rademacher, PhD, Hilary Zou, Mira Patel, PhD, Kobina Dufu, PhD, Donna Oksenberg, PhD, Katalin Kauser, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3516.
https://doi.org/10.1182/blood.V130.Suppl_1.3516.3516
Published: 2017
Journal Articles

Deficiency in Plasminogen Cause Decreased Vascularity in Sold Tissue Organs and Bone

Nicholas Mignemi, Heather Cole, Masato Yausa, M.D., David Gailani, MD, Jay L. Degen, PhD, Jonathan G Schoenecker, MD PhD
Journal: Blood
Blood (2011) 118 (21): 857.
https://doi.org/10.1182/blood.V118.21.857.857
Published: 2011
Journal Articles

Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models

Christopher W Schaefer, M.S., Deepika Lal, M.S., R Robert Vethanayagam, PhD, Joseph A Spernyak, PhD, Mukund Seshadri, PhD, Eunice S. Wang, MD
Journal: Blood
Blood (2011) 118 (21): 4293.
https://doi.org/10.1182/blood.V118.21.4293.4293
Published: 2011
Journal Articles

Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency

Joseph S. Palumbo, Kathryn E. Talmage, Hong Liu, Christine M. La Jeunesse, David P. Witte, Jay L. Degen
Journal: Blood
Blood (2003) 102 (8): 2819–2827.
https://doi.org/10.1182/blood-2003-03-0881
Published: 2003